Testing effectiveness (Phase 2)Ended earlyNCT00612066
What this trial is testing
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
Who this might be right for
Cushing's Disease
Jonsson Comprehensive Cancer Center 2